Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Validation of a Quality of Life Instrument in Spanish Patients With Rheumatic Diseases: The Rosser Classification System.

Leon L, Rodriguez-Rodriguez L, Aguilar MD, Jover JÁ, Vadillo C, Redondo M, Abasolo L.

J Clin Rheumatol. 2019 Mar;25(2):78-84. doi: 10.1097/RHU.0000000000000774.

PMID:
29561466
2.

Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.

Leon L, Rodriguez-Rodriguez L, Freites D, Arietti L, Morado I, Vadillo C, Lamas JR, Fernandez B, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):173. Epub 2018 Feb 6. No abstract available.

3.

Treatment with methotrexate and risk of relapses in patients with giant cell arteritis in clinical practice.

Leon L, Rodriguez-Rodriguez L, Morado I, Rosales Z, Vadillo C, Freites D, Macarron P, Fernandez-Gutierrez B, Blanco M, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):121-128. Epub 2017 Dec 6.

PMID:
29303708
4.

Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.

Leon L, Gomez A, Vadillo C, Pato E, Rodriguez-Rodriguez L, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):29-35. Epub 2017 Jun 6.

5.

Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.

Leon L, Rodriguez-Rodriguez L, Freites D, Arietti L, Morado I, Vadillo C, Lamas JR, Fernandez B, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):165-170. Epub 2017 Jan 23.

PMID:
28134073
6.

Dose down-titration of biological DMARDs in patients with rheumatoid arthritis over time and in daily clinical practice.

Rodriguez-Rodriguez L, Leon L, Lamas JR, Gomez A, Vadillo C, Blanco M, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):872-879. Epub 2016 May 19.

PMID:
27214094
7.

Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions.

Abasolo L, Leon L, Rodriguez-Rodriguez L, Tobias A, Rosales Z, Maria Leal J, Castaño V, Vadillo C, Macarron P, Fontsere O, Jover JA.

Semin Arthritis Rheum. 2015 Apr;44(5):506-513. doi: 10.1016/j.semarthrit.2014.11.003. Epub 2014 Nov 18.

PMID:
25532946
8.

Health-related quality of life as a main determinant of access to rheumatologic care.

Leon L, Jover JA, Loza E, Zunzunegui MV, Lajas C, Vadillo C, Fontsere O, Rodriguez-Rodriguez L, Martinez C, Fernandez-Gutierrez B, Abasolo L.

Rheumatol Int. 2013 Jul;33(7):1797-804. doi: 10.1007/s00296-012-2599-6. Epub 2013 Jan 11.

PMID:
23306593
9.

Effectiveness of an early cognitive-behavioral treatment in patients with work disability due to musculoskeletal disorders.

Leon L, Jover JA, Candelas G, Lajas C, Vadillo C, Blanco M, Loza E, Perez MA, Redondo M, Abasolo L.

Arthritis Rheum. 2009 Jul 15;61(7):996-1003. doi: 10.1002/art.24609.

10.

Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain.

Lopez-Gonzalez R, Hernandez-Garcia C, Abasolo L, Morado I, Lajas C, Vadillo C, Pato E, Fernandez-Gutierrez B, Jover JA, Loza E; emAR Study Group.

Scand J Rheumatol. 2008 Nov-Dec;37(6):419-26. doi: 10.1080/03009740802055992.

PMID:
18609260
11.

[Reduction in time until first treatment with disease modifying treatment in patients with rheumatoid arthritis].

Clemente D, Hernández-García C, Abásolo L, Villaverde V, Lajas C, Loza E, López-González R, Vadillo C, Fernández-Gutiérrez B, Morado I, Angel Jover J; el Grupo de Estudio emAR.

Reumatol Clin. 2007 Nov;3(6):245-50. doi: 10.1016/S1699-258X(07)73698-7. Epub 2008 Nov 13. Spanish.

12.

Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain.

Loza E, Abásolo L, Clemente D, López-González R, Rodríguez L, Vadillo C, Fernández-Gutiérrez B, Macarrón P, Jover JA, Hernández-García C.

J Rheumatol. 2007 Jul;34(7):1485-90. Epub 2007 Jun 1.

PMID:
17552047
13.

B cell activation in rheumatoid arthritis patients under infliximab treatment.

De Miguel S, Jover JA, Vadillo C, Judez E, Loza E, Fernandez-Gutierrez B.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6):726-32.

PMID:
14740451
14.

Increased risk of tuberculosis in patients with rheumatoid arthritis.

Carmona L, Hernández-García C, Vadillo C, Pato E, Balsa A, González-Alvaro I, Belmonte MA, Tena X, Sanmartí R; EMECAR Study Group.

J Rheumatol. 2003 Jul;30(7):1436-9.

PMID:
12858438

Supplemental Content

Loading ...
Support Center